Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 9055 [2013-02790]

Download as PDF 9055 Federal Register / Vol. 78, No. 26 / Thursday, February 7, 2013 / Notices stakeholder meeting, progress toward better respirators for healthcare workers will be discussed. FOR FURTHER INFORMATION CONTACT: Dr. Ronald E. Shaffer, Senior Scientist, NIOSH NPPTL Office of the Director at NPPTLEventsHealthcar@cdc.gov, telephone (412) 386–6111, fax (412) 386–6617. other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: January 29, 2013. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. BILLING CODE 4163–18–P Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–02791 Filed 2–6–13; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, Announces the Following Meeting ICD–9–CM Coordination and Maintenance Committee (C&M) meeting. NAME: DEPARTMENT OF HEALTH AND HUMAN SERVICES TIME AND DATE: BILLING CODE 4163–19–P Centers for Disease Control and Prevention PLACE: DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review [FR Doc. 2013–02742 Filed 2–6–13; 8:45 am] Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial review mstockstill on DSK4VPTVN1PROD with NOTICES The meeting announced below concerns Epidemiology, Prevention and Treatment of Influenza and other Respiratory Infections in Panama and Central America Region, Funding Opportunity Announcement (FOA) IP13–002; and Strengthening Global Animal-Human Interface Activities for Avian Influenza and other Zoonotic Diseases, FOA CK13–002, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 1:00 p.m.–3:00 p.m., March 28, 2013 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Epidemiology, Prevention and Treatment of Influenza and other Respiratory Infections in Panama and Central America Region, FOA IP13–002; and Strengthening Global Animal-Human Interface Activities for Avian Influenza and other Zoonotic Diseases, FOA CK13–002’’. Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718–8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and VerDate Mar<15>2010 17:45 Feb 06, 2013 Jkt 229001 The meeting announced below concerns Building Healthcare Practitioner Capacity Around HPV Vaccine Communication, Funding Opportunity Announcement (FOA) IP13–001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11:00 a.m.–5:00 p.m., April 10, 2013 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Building Healthcare Practitioner Capacity around HPV Vaccine Communication, FOA IP13–001’’. Contact Person For More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718–8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. 9:00 a.m.–5:00 p.m., March 5, 2013. Centers for Medicare and Medicaid Services (CMS) Auditorium, 7500 Security Boulevard, Baltimore, Maryland 21244. Open to the public, limited only by the space available. The meeting room accommodates approximately 240 people. The meeting will be broadcast live via Webcast at http://www.cms.gov/ live/ STATUS: Due to increased security requirements CMS has instituted stringent procedures for entrance into the building by nongovernment employees. Attendees will need to present valid government-issued picture identification, and sign-in at the security desk upon entering the building. Attendees who wish to attend a specific ICD–9–CM C&M meeting on March 5, 2013, must submit their name and organization by February 22, 2013, for inclusion on the visitor list. This visitor list will be maintained at the front desk of the CMS building and used by the guards to admit visitors to the meeting. Participants who attended previous ICD–9–CM C&M meetings will no longer be automatically added to the visitor list. You must request inclusion of your name prior to each meeting you attend. Please register to attend the meeting on-line at: http://www.cms.hhs.gov/ apps/events/. Please contact Mady Hue (410–786–4510 or Marilu.hue@cms.hhs.gov), for questions about the registration process. SECURITY CONSIDERATIONS: Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. The ICD–9–CM Coordination and Maintenance (C&M) Committee is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Ninth Revision, Clinical Modification, the International Classification of Diseases, Tenth Revision, Clinical Modification and ICD–10—Procedure Coding System [FR Doc. 2013–02790 Filed 2–6–13; 8:45 am] MATTERS TO BE DISCUSSED: BILLING CODE 4163–18–P include: PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 PURPOSE: E:\FR\FM\07FEN1.SGM 07FEN1 Agenda items

Agencies

[Federal Register Volume 78, Number 26 (Thursday, February 7, 2013)]
[Notices]
[Page 9055]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-02790]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Building Healthcare 
Practitioner Capacity Around HPV Vaccine Communication, Funding 
Opportunity Announcement (FOA) IP13-001, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 11:00 a.m.-5:00 p.m., April 10, 2013 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Building Healthcare Practitioner Capacity around HPV 
Vaccine Communication, FOA IP13-001''.
    Contact Person For More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., 
Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2013-02790 Filed 2-6-13; 8:45 am]
BILLING CODE 4163-18-P